Cargando…
Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report
INTRODUCTION: Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive disorder characterized by severe osteoporosis and eye abnormalities that leads to vision loss. In this study, we report the outcome of a short period of treatment with teriparatide in one patient with OPPG. CASE PR...
Autores principales: | Homaei, Ali, Chegini, Victoria, Saffari, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brieflands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383542/ https://www.ncbi.nlm.nih.gov/pubmed/35993038 http://dx.doi.org/10.5812/ijem-121031 |
Ejemplares similares
-
Novel Homozygous Nonsense Mutation in the LRP5 Gene in Two Siblings with Osteoporosis-pseudoglioma Syndrome
por: Heidari, Abolfazl, et al.
Publicado: (2023) -
Osteoporosis Pseudoglioma Syndrome
por: Gowda, Vykuntaraju K, et al.
Publicado: (2020) -
Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5
por: Biha, Noura, et al.
Publicado: (2016) -
Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007) -
Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)